Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. García-Beltrán, Evan C. Lam, Kerri St. Denis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India
Sarah Cherian, Varsha Potdar, Santosh Jadhav, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 256
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
Lauren Forchette, William Sebastian, Tuoen Liu
Current Medical Science (2021) Vol. 41, Iss. 6, pp. 1037-1051
Open Access | Times Cited: 224
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies
Lianlian Bian, Fan Gao, Jialu Zhang, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 4, pp. 365-373
Open Access | Times Cited: 168
Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination
Lisa Müller, Marcel Andrée, Wiebke Moskorz, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 157
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
Sandile Cele, Inbal Gazy, Laurelle Jackson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 150
Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum
Timothy A. Bates, Hans C. Leier, Zoë L. Lyski, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 123
Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants
Takuya Tada, Hao Zhou, Marie I. Samanovic, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 105
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Sandile Cele, Laurelle Jackson, David S. Khoury, et al.
Nature (2021)
Open Access | Times Cited: 102
Mutation-Specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identification of a Newly Emerging Variant with Spike L452R Mutation
Huanyu Wang, Sophonie Jean, Richard Eltringham, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 8
Open Access | Times Cited: 74
An emerging SARS-CoV-2 mutant evading cellular immunity and increasing viral infectivity
Chihiro Motozono, Mako Toyoda, Jiří Zahradník, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 72
SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines
Abbas Khan, Taimoor Ashraf Khan, Shughla Ali, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112176-112176
Open Access | Times Cited: 71
Approaches for Optimal Use of Different COVID-19 Vaccines
John P. Moore
JAMA (2021) Vol. 325, Iss. 13, pp. 1251-1251
Open Access | Times Cited: 65
The Spike Proteins of SARS-CoV-2 B.1.617 and B.1.618 Variants Identified in India Provide Partial Resistance to Vaccine-elicited and Therapeutic Monoclonal Antibodies
Takuya Tada, Hao Zhou, Belinda M. Dcosta, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 62
SARS-CoV-2 Lambda Variant Remains Susceptible to Neutralization by mRNA Vaccine-elicited Antibodies and Convalescent Serum
Takuya Tada, Hao Zhou, Belinda M. Dcosta, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 55
Sequence Analysis of 20,453 Severe Acute Respiratory Syndrome Coronavirus 2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern
S. Wesley Long, Randall J. Olsen, Paul Christensen, et al.
American Journal Of Pathology (2021) Vol. 191, Iss. 6, pp. 983-992
Open Access | Times Cited: 50
Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells
Bahareh Hafezi, Lily Chan, Jason P. Knapp, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1761-1761
Open Access | Times Cited: 49
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles
Lisha Zha, Xinyue Chang, Hongxin Zhao, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 395-395
Open Access | Times Cited: 45
Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
Liyana Ahmad
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
Henning Gruell, Kanika Vanshylla, Pinkus Tober‐Lau, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 45
Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies
Chengchao Ding, Jun He, Xiangyu Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure
Mammen P. Mammen, Pablo Tebas, Joseph Agnes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 42
mRNA-Based COVID-19 Vaccine Boosters Induce Neutralizing Immunity Against SARS-CoV-2 Omicron Variant
Wilfredo F. García-Beltrán, Kerri St. Denis, Angelique Hœlzemer, et al.
SSRN Electronic Journal (2021)
Open Access | Times Cited: 36
Monitoring the spread of the SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus; Sarbecovirus) variants in the Moscow region using targeted high-throughput sequencing
Nadezhda I. Borisova, Ivan A. Kotov, A A Kolesnikov, et al.
Problems of Virology (2021) Vol. 66, Iss. 4, pp. 269-278
Open Access | Times Cited: 33
Divergent SARS CoV-2 Omicron-specific T- and B-cell responses in COVID-19 vaccine recipients
Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 32
Experiences and challenges of African traditional medicine: lessons from COVID-19 pandemic
Polydor Ngoy Mutombo, Ossy Muganga Julius Kasilo, Peter James, et al.
BMJ Global Health (2023) Vol. 8, Iss. 8, pp. e010813-e010813
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top